While I do have some concerns about the process by which FDA is proposing this new regulatory approach, patient groups have questioned whether there are gaps in the current system that are jeopardizing patients' safety.
Pitts expresses concerns about FDA's regulatory approach and patient safety issues.
Share
More from Joe Pitts
Today's hearing will be taking a close look at the United States Preventive Services Task Force, created in 1984 as an independent, volunteer panel of 16 national experts in prevention, primary care, and evidence-based medicine and tasked…
Both the FDA and the General Accountability Office agree that there is no food safety justification for this regulatory divide.
Because of the Affordable Care Act, now over 20 million people in this country who were in that situation literally overnight are no longer in that situation.
It seems illogical that the USDA would be given the exclusive authority to oversee and regulate catfish only while the FDA regulates all other seafood.
Other voices in this conversation
